Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype

T. Ohashi, Reuben Matalon, J. A. Barranger, Y. Eto

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We tested the influence of overexpression of arylsulfatase A (ASA) on the activity of other sulfatases in fibroblasts from patients with metachromatic leukodystrophy (MLD). We demonstrated that the overexpression of ASA reduces the activity of various sulfatases by a small amount but does not induce an accumulation of glycosaminoglycan. Our results indicate that influence of ASA overexpression on other sulfatases is different from that of N-acetylgalactosamine-4-sulfatase overexpression reported by Anson et al. We conclude that gene therapy for MLD based on the transfer of a normal ASA gene to mutant cells will be feasible because the overexpression of ASA peptides in cells does not lead to profound deficiency of other sulfatases or result in a new phenotype.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalGene Therapy
Volume2
Issue number6
StatePublished - 1995
Externally publishedYes

Fingerprint

Cerebroside-Sulfatase
Metachromatic Leukodystrophy
Sulfatases
Fibroblasts
Phenotype
Genes
N-Acetylgalactosamine-4-Sulfatase
Glycosaminoglycans
Genetic Therapy
Peptides

Keywords

  • arylsulfatase A
  • gene therapy
  • glycosaminoglycan
  • metachromatic leukodystrophy
  • multiple sulfatase deficiency
  • sulfatase

ASJC Scopus subject areas

  • Genetics

Cite this

Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype. / Ohashi, T.; Matalon, Reuben; Barranger, J. A.; Eto, Y.

In: Gene Therapy, Vol. 2, No. 6, 1995, p. 363-368.

Research output: Contribution to journalArticle

@article{32ecdd2fc9d04454801cb49bf3b7f503,
title = "Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype",
abstract = "We tested the influence of overexpression of arylsulfatase A (ASA) on the activity of other sulfatases in fibroblasts from patients with metachromatic leukodystrophy (MLD). We demonstrated that the overexpression of ASA reduces the activity of various sulfatases by a small amount but does not induce an accumulation of glycosaminoglycan. Our results indicate that influence of ASA overexpression on other sulfatases is different from that of N-acetylgalactosamine-4-sulfatase overexpression reported by Anson et al. We conclude that gene therapy for MLD based on the transfer of a normal ASA gene to mutant cells will be feasible because the overexpression of ASA peptides in cells does not lead to profound deficiency of other sulfatases or result in a new phenotype.",
keywords = "arylsulfatase A, gene therapy, glycosaminoglycan, metachromatic leukodystrophy, multiple sulfatase deficiency, sulfatase",
author = "T. Ohashi and Reuben Matalon and Barranger, {J. A.} and Y. Eto",
year = "1995",
language = "English (US)",
volume = "2",
pages = "363--368",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Overexpression of arylsulfatase A gene in fibroblasts from metachromatic leukodystrophy patients does not induce a new phenotype

AU - Ohashi, T.

AU - Matalon, Reuben

AU - Barranger, J. A.

AU - Eto, Y.

PY - 1995

Y1 - 1995

N2 - We tested the influence of overexpression of arylsulfatase A (ASA) on the activity of other sulfatases in fibroblasts from patients with metachromatic leukodystrophy (MLD). We demonstrated that the overexpression of ASA reduces the activity of various sulfatases by a small amount but does not induce an accumulation of glycosaminoglycan. Our results indicate that influence of ASA overexpression on other sulfatases is different from that of N-acetylgalactosamine-4-sulfatase overexpression reported by Anson et al. We conclude that gene therapy for MLD based on the transfer of a normal ASA gene to mutant cells will be feasible because the overexpression of ASA peptides in cells does not lead to profound deficiency of other sulfatases or result in a new phenotype.

AB - We tested the influence of overexpression of arylsulfatase A (ASA) on the activity of other sulfatases in fibroblasts from patients with metachromatic leukodystrophy (MLD). We demonstrated that the overexpression of ASA reduces the activity of various sulfatases by a small amount but does not induce an accumulation of glycosaminoglycan. Our results indicate that influence of ASA overexpression on other sulfatases is different from that of N-acetylgalactosamine-4-sulfatase overexpression reported by Anson et al. We conclude that gene therapy for MLD based on the transfer of a normal ASA gene to mutant cells will be feasible because the overexpression of ASA peptides in cells does not lead to profound deficiency of other sulfatases or result in a new phenotype.

KW - arylsulfatase A

KW - gene therapy

KW - glycosaminoglycan

KW - metachromatic leukodystrophy

KW - multiple sulfatase deficiency

KW - sulfatase

UR - http://www.scopus.com/inward/record.url?scp=0029162832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029162832&partnerID=8YFLogxK

M3 - Article

C2 - 7584110

AN - SCOPUS:0029162832

VL - 2

SP - 363

EP - 368

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 6

ER -